DHR — Danaher Corporation (Stock)

Price: $221.56 · 1 day: +0.21% · 5 days: +6.34% · 1 month: +3.00% · YTD: -3.22%
As of 2026-09-23 20:03 UTC.

52-week range: $160.93 – $242.8 (currently at 74% of the range).

The read

DHR is in an uptrend, momentum firm. $225 is the level overhead; $209.63 the first support below.

6 of 6 technical checks lean bullish.

• Price vs 50-day: above
• Price vs 200-day: above
• 50d vs 200d avg: above
• MACD: bullish
• RSI momentum: 66
• 5-day tape: +6.3%

Key levels

Indicators

Next earnings: 2026-10-21.

Latest DHR news

• Stock Market Today: Dow Skids As Trump Threatens Iran; Medical Diagnostics Plays Swoon (Live Coverage) — Danaher stock rose more than 2% on Tuesday, breaking above a cup-with-handle buy point of 220.67, marking a first-stage technical pattern. The stock trades 8% above its 50-day moving average with a rising relative streng (Investor's Business Daily, 2026-09-22)
• Sepsis Diagnostics Market worth $1.22 billion by 2031 - Exclusive Report by MarketsandMarkets™ — MarketsandMarkets projects the global sepsis diagnostics market will grow from USD 0.83 billion in 2026 to USD 1.22 billion by 2031, representing a compound annual growth rate (CAGR) of 7.9%. In 2025, North America held (PR Newswire, 2026-09-11)
• Genuine Parts Company Names Leadership Teams and Board Leadership for Automotive and Industrial Businesses — Genuine Parts Company announced leadership appointments for its planned separation into two independent publicly traded companies targeted for Q1 2027. Court Carruthers, a current board member with extensive distribution (PR Newswire, 2026-09-09)
• BRC Therapeutics Appoints Biopharma Veteran Chandra Ramanathan as Executive Vice President of Commercialization and Strategy — BRC Therapeutics announced the appointment of Chandra Ramanathan, Ph.D., M.B.A., as Executive Vice President of Commercialization and Strategy. Ramanathan brings over 30 years of biopharmaceutical leadership experience f (PR Newswire, 2026-08-24)
• Veralto Signs Agreement to Acquire Cleanwater1 — Veralto announced an agreement to acquire Cleanwater1 for $465 million ($452 million net after estimated tax benefits), representing a 17x multiple of Cleanwater1's last twelve months adjusted EBITDA. The acquisition exp (PR Newswire, 2026-08-19)
• Masimo Receives CE Mark for AI-Powered smartSedLine™ Brain Function Monitor to Advance Anesthetic Management — Masimo, a Danaher company, announced that its smartSedLine brain function monitor has received CE Mark approval for distribution in applicable European markets. The device utilizes an AI-powered Patient State Index algor (PR Newswire, 2026-08-18)
• DANAHER CORP /DE/ — Form 8-K: 5.02 Departure/Election of Directors or Officers; 7.01 Regulation FD Disclosure; 8.01 Other Events; 9.01 Financial Statements and Exhibits — Danaher Corp filed a Form 8-K with the SEC on August 3, 2026, reporting items related to the departure or election of directors or officers (Item 5.02), a Regulation FD disclosure (Item 7.01), other events (Item 8.01), a (SEC EDGAR, 2026-08-03)
• Inside Larry Culp's playbook for fixing GE | Fortune — General Electric's transformation under CEO Larry Culp has generated approximately $700 billion in aggregate equity value across GE HealthCare, GE Vernova, and GE Aerospace, roughly doubling the S&P 500's annualized retu (Fortune, 2026-07-24)

Explore more

Interactive DHR chart and analyst chat · Market terminal — movers, signals and news · Use MarketCrew inside Claude · Use MarketCrew inside ChatGPT · Top gainers today · 52-week highs